Patents by Inventor RICHARD STRATTON

RICHARD STRATTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220143130
    Abstract: The present disclosure provides novel peptides that having immunomodulatory activities in vitro and in vivo. The peptides can include a particular striapathic region of alternating hydrophilic and hydrophobic modules that can adopt an amphipathic conformation under physiological conditions. This disclosure provides peptides that can specifically bind to key functional regions on one or more signaling proteins, particularly pro-inflammatory cytokines, macrophage inhibition proteins, and histone regulation proteins. This disclosure includes peptides that are sufficiently stable in the circulation to allow for intravenous administration. Pharmaceutical compositions including the subject peptides are also provided. The subject peptides find use in methods of modulating macrophage activity. In some cases, the peptide is a CD206-binding agent. Also provided are methods of treating a subject for a condition associated with chronic inflammation using the peptides and compositions of this disclosure.
    Type: Application
    Filed: November 29, 2021
    Publication date: May 12, 2022
    Inventors: Jesse M. Jaynes, Henry Wilfred Lopez, George R. Martin, Clayton Yates, Bahja Ahmed Abdi, Richard Stratton, Charles Garvin
  • Publication number: 20030013804
    Abstract: Stable emulsions for use in the field of adhesives have been prepared using a non lignin, nonionic surfactant in phenol-aldehyde/wax emulsions. The adhesives have utility for binding wood particles into a unitary mass such as used in the strandboard, chipboard, particles board, plywood, laminated veneer lumber and high and medium density fiberboard industries and exhibit storage stability.
    Type: Application
    Filed: June 13, 2002
    Publication date: January 16, 2003
    Inventors: Earl K. Phillips, Richard Stratton, Dale Leeper
  • Publication number: 20020028847
    Abstract: The present invention is directed to methods for treating fibrosis related diseases and disorders, particularly scleroderma by treating a patient in need with a pharmaceutically efficacious amount of a prostacyclin derivative. The most preferred prostacyclin derivatives are cicaprost and iloprost.
    Type: Application
    Filed: July 25, 2001
    Publication date: March 7, 2002
    Applicant: Fibrogen, Inc.
    Inventors: Richard Stratton, Carol Black, George R. Martin, David F. Carmichael
  • Publication number: 20010006979
    Abstract: The present invention is directed to methods for treating fibrosis related diseases and disorders, particularly scleroderma by treating a patient in need with a pharmaceutically efficacious amount of a prostacyclin derivative. The most preferred prostacyclin derivatives are cicaprost and iloprost.
    Type: Application
    Filed: July 8, 1999
    Publication date: July 5, 2001
    Inventors: RICHARD STRATTON, CAROL M. BLACK, GEORGE R. MARTIN, DAVID F. CARMICHAEL
  • Patent number: 4830667
    Abstract: A copper converting process starting with white metal or a mixture of white metal and metallic copper in which oxidizing gas contacts the molten copper mass either at or near the top surface of the molten mass while the mass is sparged with an inert gas from at or near the bottom of the mass and sparging is continued after contact with the oxidizing gas ceases.
    Type: Grant
    Filed: March 17, 1988
    Date of Patent: May 16, 1989
    Assignee: Inco Limited
    Inventors: Samuel W. Marcuson, Carlos M. Diaz, James A. E. Bell, Haydn Davies, Richard Stratton-Crawley